Robotic vs. Human Assistance in Colorectal Surgery: Which is More Effective?
"A new study investigates whether robotic scope holders like Soloassist® can improve laparoscopic colorectal resections compared to traditional human assistance."
Laparoscopic surgery has transformed colorectal procedures, offering minimally invasive approaches that benefit patients worldwide. As techniques evolve, two major trends are emerging: single-incision laparoscopic surgery (SILS) to reduce scarring, and the integration of mechanical supporting equipment like robot-assisted surgery. These advancements aim to enhance precision, reduce surgeon fatigue, and improve patient outcomes.
Among the innovations in surgical technology, robotic scope holders have garnered attention. The Soloassist® system, a joystick-guided endoscope remote control, allows surgeons to control the field of view, potentially offering greater control and stability during procedures. This system, in particular, has been applied in all laparoscopic surgeries including emergency operations.
A recent study has evaluated the efficacy of the Soloassist® system in laparoscopic colorectal resections, comparing it to traditional human scope assistance. The study aimed to determine if Soloassist® can reduce operative time, blood loss, and other key surgical metrics, ultimately assessing its value as a robot-assisted surgical instrument.
Adoption and Access
A Hanaoka et al. study of 28,711 patients with stage I–III rectal cancer treated between 2018 and 2024 found that 15.3% underwent robotic surgery, compared with 72.3% laparoscopic and 12.4% open procedures. Robotic adoption for rectal cancer increased by 4.28% annually and surpassed laparoscopic and open approaches by 2018. Access remains uneven: robotics was used predominantly in metropolitan centers, accounting for 87.2% of cases compared with 1.5% in rural areas.
Laparoscopy and Robotic Assistance
Laparoscopy remains an established minimally invasive approach in colorectal surgery, while robotic technology has been increasingly adopted as an alternative. The cited review describes robotic surgery as part of multidisciplinary treatment strategies for colorectal cancer, including locally advanced rectal cancer. Robotic systems are gaining popularity partly because they may address limitations of laparoscopy in narrow pelvic spaces and inflammatory conditions, although future multicenter randomized trials and standardized outcome reporting are still needed to define their benefits, limitations, and cost-effectiveness.
From Innovation to Colorectal Practice
Historical reviews of robotic colorectal surgery trace the development of robotic surgical technology through important phases and landmarks. Their purpose is to explain how robotic technology was implemented in surgery and to provide context for current advances. Together, these reviews present the field as an evolving development whose historical milestones help frame contemporary colorectal applications.
Soloassist® vs. Human Assistance: Key Findings
The study, which involved 273 laparoscopic colorectal resections, compared 130 cases with human assistance (HA group) to 143 cases using Soloassist® (SA group). Researchers analyzed operative time, blood loss, setup time, length of hospital stay, and the number of participating surgeons. Statistical methods, including logistic regression, were used to balance potential biases between the groups.
- Reduced Surgeon Involvement: The Soloassist® group required fewer participating surgeons (2.5 vs. 3.3 in the human assistance group, p<0.01).
- Operative Time: While the Soloassist® group showed a trend toward shorter operative times, the difference was not statistically significant (268.5 min vs. 287.0 min in the human assistance group, p=0.07). However, significant difference was demonstrated only in right-side colectomy (p=0.01).
- Lymph Node Dissection: The total number of dissected lymph nodes was higher in the SA group (HA group: 18.6 vs. SA group: 21.0, p=0.02).
- No Significant Differences: Setup time, conversion rate, perioperative complications, and length of hospital stay were similar between the two groups. Importantly, there were no system-specific adverse events associated with Soloassist®.
Current Evidence and Environmental Costs
Recent research is evaluating robotic platforms for colorectal cancer therapy and comparing their effectiveness with laparoscopic surgery. One cited review concludes that robotic colorectal surgery may provide oncological and perioperative outcomes at least comparable to laparoscopy, while offering technical advantages particularly in rectal surgery. Environmental evidence summarized by Papadopoulou et al. reports that robotic colorectal procedures generated approximately 43.5% more greenhouse gas emissions and 24% more surgical waste than laparoscopic procedures.
Limits of the Evidence
Current reviews emphasize that robotic colorectal surgery must be assessed through both clinical and economic evidence. A 2025 commentary identifies clinical advantages alongside current limitations and future questions about robotics in colorectal cancer treatment. The available source material therefore supports a balanced interpretation: robotics is an evolving option, but its advantages should not be separated from economic considerations and the need for further research.
Robotic Versus Laparoscopic Surgery
Colorectal cancer surgery is commonly performed with either robotic-assisted colorectal surgery or laparoscopic colorectal surgery, and comparative studies have been designed to evaluate their clinical and surgical outcomes. The cited surgical review reports that robotic techniques offer distinct advantages over traditional laparoscopy in complex anatomical regions. In particular, enhanced dexterity and range of motion may be valuable when operating in technically demanding areas.
The Future of Surgical Assistance: Efficiency and Innovation
The study suggests that Soloassist® offers a safe and feasible alternative to human scope assistance in laparoscopic colorectal resection. By potentially reducing the number of surgeons required and maintaining comparable surgical outcomes, Soloassist® provides possibilities for saving human resources in laparoscopic colorectal resection without prolonged operative time or system-specific morbidity.
A Conditional Choice
The available evidence suggests that robotic and human-led surgical care should not be framed as simple substitutes. Robotic systems may offer technical support in selected colorectal procedures, while outcomes still depend on clinical judgment, team expertise, and the circumstances of each patient. A cautious synthesis is that robotics may complement human assistance rather than eliminate its importance.
Emerging Directions
Future work is expected to build on the historical evolution of robotic colorectal interventions and explore emerging robotic tools and systems. Reviews are examining clinical benefits, new technologies, ethical considerations, and future trends. A 2026 evidence summary reports that long-term REAL trial outcomes suggest possible oncologic benefits in mid-to-low rectal cancer, while cost and operative time remain trade-offs.
Beyond the Operating Room
Robotic colorectal surgery is shaped by more than technical capability alone. Adoption, training, institutional resources, evidence quality, and financial considerations may influence whether a robotic approach is appropriate or available. These systemic factors make it difficult to identify one universally superior method.
Human Judgment in Surgery
Robotic assistance does not remove the need for human expertise in colorectal care. Surgeons and multidisciplinary teams remain responsible for selecting patients, interpreting evidence, managing unexpected findings, and integrating surgery with broader treatment decisions. The practical value of robotics is therefore likely to depend on how effectively clinicians use the technology in real-world settings.
One of the distinct advantages of the Soloassist® system lies in its intuitive design and ease of use. The joystick control allows surgeons to manipulate the laparoscope with dexterity, while the slim design of the robotic arm minimizes interference with surgical instruments. The system's compatibility with existing operating room setups further enhances its practicality.
While the present study offers valuable insights, future research should focus on prospective, randomized trials comparing Soloassist® to both human assistance and full-robotic surgery. Further investigation into long-term outcomes and cost-effectiveness will help determine the optimal role of robotic scope holders in modern surgical practice.